The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...
HealthDay on MSN2d
FDA approves wearable infusion device for advanced Parkinson diseaseOnapgo is a subcutaneous apomorphine infusion device for the treatment of motor fluctuations in patients with advanced disease.
More than 1 million Americans have Parkinson’s disease, a neurological illness ... gained a lot of weight and couldn’t walk without a cane. Q: What got you from denial to inspirational athlete?
This is not the kind of honor I ever anticipated on my life bingo card. But I never expected a Parkinson’s disease diagnosis, either. Or starting a foundation that bears my name, which has ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback